wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42617282-EB67CB20-A09F-4B9A-A4E1-90CAEB50847A
Q42617282-EB67CB20-A09F-4B9A-A4E1-90CAEB50847A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42617282-EB67CB20-A09F-4B9A-A4E1-90CAEB50847A
Angiotensin converting enzyme inhibitors remain the first treatment of choice.
P2860
Q42617282-EB67CB20-A09F-4B9A-A4E1-90CAEB50847A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42617282-EB67CB20-A09F-4B9A-A4E1-90CAEB50847A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
da9484590cecefa1129a384e4407281d2e7d95ca
P2860
Combination pravastatin and valsartan treatment has additive beneficial effects to simultaneously improve both metabolic and cardiovascular phenotypes beyond that of monotherapy with either drug in patients with primary hypercholesterolemia.